
Tetrahedron p. 3157 - 3162 (1982)
Update date:2022-07-29
Topics:
Rigaudy, J.
Seuleiman, A.M.
Cuong, Nguyen Kim
Treatment of meso-substituted 9-bromoanthracenes bearing no hydrogen in the α position with potassium phenoxide in DMF gives rise to a competition between nucleophilic substitution and reductive dehalogenation.Derivatives carrying electron attracting groups, 1c (Br), 1e (CN) and 1f (NO2), react essentially by substitution leading to phenolic ethers 2, whereas with non-activated bromides, 1a (H), 1b (C6H5) and 1d (OC6H5), the main reaction is a reduction to anthracenes 3 which should arise from an electron transfer.A reduction of 9-bromoanthracene into anthracene is also observed with sodium methoxide and it is shown, by labelling, that this one must result from a hydride transfer from methoxide.It may be applied to the specific meso-monodeuterization of various anthracenic derivatives.
View MoreLinyi Shengxin Pharmaceutical R&D Co., Ltd
Contact:+86-18653953873
Address:West First of Yufeng Road, Yishui County
BrightGene Bio-Medical Technology Co., Ltd.
website:https://en.bright-gene.com/
Contact:+86-512-62551801
Address:Building C25 - C31, No. 218 Xinghu Road, Suzhou Industrial Park, Suzhou, Jiangsu, China.
Suzhou HeChuang Chemical Co.,Ltd.
Contact:+86-512-88800520
Address:No.9 Guanchao Rd,Changshu Advanced Materials Industy Park
Contact:+86-15995924277
Address:WuZhongOu suzhou new south road 89
Contact:+86-371-67759225
Address:No.32, Jinsuo Road, High-tech Zone
Doi:10.3987/COM-99-8486
(1999)Doi:10.1021/ja00978a033
(1967)Doi:10.1246/bcsj.71.1667
(1998)Doi:10.1021/om400859q
(2013)Doi:10.1080/00397919308009784
(1993)Doi:10.1016/S0277-5387(00)86218-X
(1991)